Literature DB >> 26037458

Cognitive reserve and β-amyloid pathology in Parkinson disease.

Carolyn Lucero1, Meghan C Campbell2, Hubert Flores3, Baijayanta Maiti4, Joel S Perlmutter5, Erin R Foster6.   

Abstract

INTRODUCTION: Dementia in Parkinson disease (PD) is associated with abnormal accumulation of proteins, including β-amyloid, in cortical regions. High cognitive reserve capacity may protect cognition from β-amyloid and delay the onset of dementia. We tested the cognitive reserve theory in PD by determining whether educational attainment, a proxy for cognitive reserve, modifies the correlation between cortical β-amyloid accumulation and cognitive impairment.
METHODS: PD participants (N = 155) underwent MRI to quantify brain volume and [(11)C] PiB PET imaging to quantify fibrillar β-amyloid deposition. Mean cortical binding potentials (MCBP) were calculated for each participant, with higher scores indicating more fibrillar β-amyloid. Global cognitive function was assessed using the Clinical Dementia Rating (CDR) and Mini-Mental State Examination (MMSE). Multiple linear regression analysis was used to determine whether education modified the relationship between MCBP and cognitive function after controlling for brain volume.
RESULTS: MCBP interacted with educational attainment to predict scores on each of the cognitive outcome measures (ps ≤ 0.02). Post-hoc analysis revealed that the effect of MCBP on cognitive function changed once the level of education reached 16 years. For participants with less than 16 years of education (n = 68), higher MCBP correlated with worse cognitive function, with MCBP accounting for 8-30% of the variance in MMSE and CDR scores (ps ≤ 0.02). For participants with at least 16 years of education (n = 87), MCBP did not correlate with MMSE or CDR scores (R(2)s < 0.02, ps ≥ 0.17).
CONCLUSION: These findings provide support for the cognitive reserve theory in PD and suggest that education may protect PD patients' cognition against cortical β-amyloid pathology.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Cognitive reserve; Dementia; Education; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 26037458      PMCID: PMC4509801          DOI: 10.1016/j.parkreldis.2015.05.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Amyloid imaging of Lewy body-associated disorders.

Authors:  Erin R Foster; Meghan C Campbell; Michelle A Burack; Johanna Hartlein; Hubert P Flores; Nigel J Cairns; Tamara Hershey; Joel S Perlmutter
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Influence of late-life cognitive activity on cognitive health.

Authors:  Robert S Wilson; Eisuke Segawa; Patricia A Boyle; David A Bennett
Journal:  Neurology       Date:  2012-04-04       Impact factor: 9.910

3.  Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.

Authors:  Paul T Kotzbauer; Nigel J Cairns; Meghan C Campbell; Allison W Willis; Brad A Racette; Samer D Tabbal; Joel S Perlmutter
Journal:  Arch Neurol       Date:  2012-10

Review 4.  Mild cognitive impairment and cognitive reserve in Parkinson's disease.

Authors:  Michele Poletti; Murat Emre; Ubaldo Bonuccelli
Journal:  Parkinsonism Relat Disord       Date:  2011-04-12       Impact factor: 4.891

5.  Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases.

Authors:  Meghan C Campbell; Joanne Markham; Hubert Flores; Johanna M Hartlein; Alison M Goate; Nigel J Cairns; Tom O Videen; Joel S Perlmutter
Journal:  Neurology       Date:  2013-07-03       Impact factor: 9.910

6.  Education, the brain and dementia: neuroprotection or compensation?

Authors:  Carol Brayne; Paul G Ince; Hannah A D Keage; Ian G McKeith; Fiona E Matthews; Tuomo Polvikoski; Raimo Sulkava
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

7.  Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.

Authors:  Stephen N Gomperts; Joseph J Locascio; Dorene Rentz; Andrea Santarlasci; Marta Marquie; Keith A Johnson; John H Growdon
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

8.  Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.

Authors:  Chandana Buddhala; Meghan C Campbell; Joel S Perlmutter; Paul T Kotzbauer
Journal:  Neurobiol Aging       Date:  2014-08-04       Impact factor: 4.673

Review 9.  Cognitive reserve in Parkinson's disease: a systematic review and meta-analysis.

Authors:  John V Hindle; Anthony Martyr; Linda Clare
Journal:  Parkinsonism Relat Disord       Date:  2013-08-29       Impact factor: 4.891

Review 10.  Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses.

Authors:  Xiangfei Meng; Carl D'Arcy
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more
  13 in total

1.  Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.

Authors:  Jennifer Y Y Szeto; Courtney C Walton; Alexandra Rizos; Pablo Martinez-Martin; Glenda M Halliday; Sharon L Naismith; K Ray Chaudhuri; Simon J G Lewis
Journal:  NPJ Parkinsons Dis       Date:  2020-01-07

2.  Emergent Functional Network Effects in Parkinson Disease.

Authors:  Caterina Gratton; Jonathan M Koller; William Shannon; Deanna J Greene; Baijayanta Maiti; Abraham Z Snyder; Steven E Petersen; Joel S Perlmutter; Meghan C Campbell
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

3.  Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.

Authors:  Neha Shah; Kirk A Frey; Martijn L T M Müller; Myria Petrou; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Roger L Albin; Nicolaas I Bohnen
Journal:  Mov Disord       Date:  2015-09-18       Impact factor: 10.338

Review 4.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

5.  Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.

Authors:  Zhi-Fen Dong; Cai-Shan Wang; Ying-Chun Zhang; Ying Zhang; Yu-Jing Sheng; Hua Hu; Wei-Feng Luo; Chun-Feng Liu
Journal:  Chin Med J (Engl)       Date:  2017-10-05       Impact factor: 2.628

6.  Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease.

Authors:  Deborah L Harrington; Qian Shen; Rebecca J Theilmann; Gabriel N Castillo; Irene Litvan; J Vincent Filoteo; Mingxiong Huang; Roland R Lee
Journal:  Front Aging Neurosci       Date:  2018-10-23       Impact factor: 5.750

7.  Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.

Authors:  Jennifer Y Y Szeto; Courtney C Walton; Alexandra Rizos; Pablo Martinez-Martin; Glenda M Halliday; Sharon L Naismith; K Ray Chaudhuri; Simon J G Lewis
Journal:  NPJ Parkinsons Dis       Date:  2020-01-07

Review 8.  Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?

Authors:  Ming-Ching Wen; Ling Ling Chan; Louis C S Tan; Eng King Tan
Journal:  Transl Neurodegener       Date:  2017-09-13       Impact factor: 8.014

9.  Professional occupation and the risk of Parkinson's disease.

Authors:  S K L Darweesh; M K Ikram; M J Faber; N M de Vries; C A Haaxma; A Hofman; P J Koudstaal; B R Bloem; M A Ikram
Journal:  Eur J Neurol       Date:  2018-08-06       Impact factor: 6.089

Review 10.  Current radiotracers to image neurodegenerative diseases.

Authors:  Solveig Tiepolt; Marianne Patt; Gayane Aghakhanyan; Philipp M Meyer; Swen Hesse; Henryk Barthel; Osama Sabri
Journal:  EJNMMI Radiopharm Chem       Date:  2019-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.